KAPA AMEX
Kairos Pharma, Ltd.
1W: -9.3%
1M: -1.3%
3M: -42.6%
YTD: -69.4%
1Y: -80.3%
$1.56
+0.00 (+0.00%)
Weekly Expected Move ±8.7%
$1
$1
$2
$2
$2
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
12 relationships12
As Filer
counterparties named
0
As Counterparty
mentioned by others
6
Rel. Types
2024-09-17
Earliest Filing
2026-03-02
Latest Filing
supplier: 3
customer: 3
target: 2
partner: 2
acquirer: 1
licensee: 1
Counterparties (Filed by KAPA)
12 relationshipsCompanies named in KAPA's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Kairos Pharma, Ltd. | KAPA | acquirer | Acquiring 100% of CL-273 development and commercialization rights from Celyn Therapeutics. | 2026-03-02 | View |
| Celyn Therapeutics, Inc. | — | target | Selling 100% of CL-273 development and commercialization rights to Kairos Pharma, Ltd. | 2026-03-02 | View |
| Cedars-Sinai Medical Center | — | licensee | Licensor of exclusive license agreements for mitochondrial/genomic DNA depletion and endoglin antagonism therapies. | 2025-10-07 | View |
| Enviro Therapeutics, Inc. | — | partner | Original licensee of exclusive agreements, a wholly-owned subsidiary of Kairos Pharma, Ltd., entering dissolution. | 2025-10-07 | View |
| Kairos Pharma, Ltd. | KAPA | partner | New licensee acquiring all rights and responsibilities from Enviro Therapeutics, Inc. via novation. | 2025-10-07 | View |
| Barretto Pacific Corporation | — | supplier | Provider of investor relations and public information dissemination services | 2025-06-12 | View |
| Kairos Pharma, Ltd. | KAPA | customer | Client engaging Barretto Pacific Corporation for investor relations services | 2025-06-12 | View |
| KAIROS PHARMA, LTD. | KAPA | customer | Client engaging CEO.CA for consulting and advertising services | 2024-09-27 | View |
| CEO.CA TECHNOLOGIES LTD. | — | supplier | Service provider offering financial information and communications services | 2024-09-27 | View |
| PreCheck Health Services, Inc. | — | supplier | Provides genetic sequencing and bioassay services for clinical trials. | 2024-09-24 | View |
| Kairos Pharma, Ltd. | KAPA | customer | Engages service provider for biomarker identification in cancer clinical trials. | 2024-09-24 | View |
| Kairos Pharma, Ltd. | KAPA | target | Company issuing shares in the offering | 2024-09-17 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-14 | Regulation FD; Exhibits | View | |
| 2026-08-21 | Bylaws Amendment; Regulation FD; Exhibits | View | |
| 2026-07-22 | Material Agreement; Other Events; Exhibits | Agreement | View |
| 2026-07-15 | Other Events; Exhibits | View | |
| 2026-06-30 | Shareholder Vote | View | |
| 2026-06-04 | Other Events; Exhibits | View | |
| 2026-05-18 | Other Events; Exhibits | View | |
| 2026-03-02 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2026-02-26 | Other Events; Financial Statements and Exhibits | View | |
| 2025-10-15 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-10-07 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2025-09-18 | Other Events; Financial Statements and Exhibits | View | |
| 2025-09-11 | Other Events; Financial Statements and Exhibits | View | |
| 2025-09-03 | Other Events; Financial Statements and Exhibits | View | |
| 2025-07-15 | Other Events; Financial Statements and Exhibits | View | |
| 2025-06-12 | Entry into Material Definitive Agreement; Submission of Matters to a Vote of Security Holders; Finan | Agreement | View |
| 2025-06-03 | Other Events; Financial Statements and Exhibits | View | |
| 2025-04-28 | Changes in Registrant's Certifying Accountant; Financial Statements and Exhibits | View | |
| 2025-04-24 | Other Events; Financial Statements and Exhibits | View | |
| 2025-03-20 | Other Events; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR